Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIA (N2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002550
What this trial is testing

Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 429
Testing effectiveness (Phase 2)Looking for participantsNCT06693336
What this trial is testing

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
ToLymph Inc. 42
Testing effectiveness (Phase 2)UnknownNCT05024266
What this trial is testing

Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma

Who this might be right for
Lung Squamous Cell CarcinomaNeoadjuvant TherapyImmunotherapy
First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)UnknownNCT04965831
What this trial is testing

Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT)

Who this might be right for
Lung Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Large-scale testing (Phase 3)Study completedNCT00880971
What this trial is testing

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

Who this might be right for
Thoracic NeoplasmsNon-small Cell Lung Cancer
Chinese Academy of Medical Sciences 394
Testing effectiveness (Phase 2)Study completedNCT00600587
What this trial is testing

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Guangdong Provincial People's Hospital 24
Large-scale testing (Phase 3)Active Not RecruitingNCT06077760
What this trial is testing

Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 868
Testing effectiveness (Phase 2)UnknownNCT01926483
What this trial is testing

Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection

Who this might be right for
Non-small Cell Lung Cancer Stage IIIA
Zhejiang Cancer Hospital 75
Large-scale testing (Phase 3)UnknownNCT00410683
What this trial is testing

Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery

Who this might be right for
Non-small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 500
Testing effectiveness (Phase 2)UnknownNCT00616499
What this trial is testing

Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Yonsei University 35
Not applicableWithdrawnNCT01314677
What this trial is testing

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT04422392
What this trial is testing

Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 93
Large-scale testing (Phase 3)Ended earlyNCT00113386
What this trial is testing

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 19
Testing effectiveness (Phase 2)UnknownNCT02977169
What this trial is testing

To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IIIARadiotherapy
Shanghai Chest Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT00063258
What this trial is testing

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00003231
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04062708
What this trial is testing

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Alliance Foundation Trials, LLC. 38
Large-scale testing (Phase 3)Ended earlyNCT00273507
What this trial is testing

Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3

Who this might be right for
Non-small Cell Lung Cancer
Rigshospitalet, Denmark 270
Early research (Phase 1)Study completedNCT00005065
What this trial is testing

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Study completedNCT00030771
What this trial is testing

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients

Who this might be right for
Lung Cancer
Swiss Cancer Institute 232
Next Page